Providers

The Eve Appeal is a registered charity, formed in 2005. Since then, we have worked hard to raise money to fund the world-class research programme at the Department of Women's Cancer based at University College London (UCL).

The Department's vital and much-needed research will benefit women in the UK and worldwide.

A report by an independent panel reviewing the Department's work and progress (the Pattison Review Report 2009) acknowledges the importance of The Eve Appeal's role: "The Eve Appeal has consistently contributed about 15% of the total research income. However, its contributions have been disproportionately important because they have pump-primed new projects, supported highly innovative work and covered gaps in funding allowing projects to maintain momentum. The national and international standing of the projects to which it has contributed is testament to the effectiveness of The Eve Appeal support."

Major breakthroughs are already being achieved towards improving survival rates of women with gynaecological cancers through the Department's pioneering research into screening, early diagnosis and risk prediction. To build on these successes and save women's lives, raising urgent and on-going funds is critical.

Promoting awareness is vital too. The Eve Appeal therefore disseminates information about the research we fund. We publicise - and provide information on - gynaecological cancers. We contribute to the development of policy and campaigns. And we work in partnership with others to improve the healthcare and support of women.

Ovarian Cancer Action is the UK’s leading ovarian cancer charity. Its focus is to improve the prognosis of all women diagnosed with ovarian cancer. It aims to transform ovarian cancer treatment and improve survival through creating a research environment that encourages scientific breakthrough; this is why it is vital to establish and continue to fund the UK’s first research centre dedicated solely to ovarian cancer.

OCA's passion is to reach every woman and GP in the UK with key messages about ovarian cancer and its symptoms. This, we feel, will contribute to ensuring that a greater proportion of women are diagnosed as early as possible giving women a greater chance of survival.

Postgraduate medical student at Warwick Medical School. BSc Biomedical Science (Hons). Interested in neurology, stroke medicine, primary care and care of the elderly. Outside of curriculum-based medicine, my interests are clinical research, quality improvement projects, and business.

Rod Jacques has been involved in Sports Medicine for the last 21 years and joined the EIS in 2003 having previously worked at the British Olympic Medical Centre in London.

Based at the University of Bath, Rod attended the Atlanta, Sydney, Athens and Beijing Olympics with Team GB and the Kuala Lumpur and Manchester Commonwealth Games with the England Team.

He did the London Hospital Diploma course in Sports Medicine, qualifying with distinction and the David Ritchie prize in 1990. He also obtained the Society of Apothecaries Diploma in Sports Medicine, and is a Fellow of the Faculty of Sport and Exercise Medicine and am current Vice-President.

He was appointed to the British Olympic Medical Centre, London in 1998 – 2001 and joined the EIS in 2003.

Mark Hamer graduated in Sport and Exercise Science (1996) from The University of Birmingham, completed an MSc in Sports Sciences (1999) at Brunel University and later received his PhD in Exercise Physiology from De Montfort University (2002). He spent eleven years at UCL as a researcher in Epidemiology and Public Health funded by the British Heart Foundation before taking up the role of Professor in Exercise as Medicine at Loughborough University in 2015. He later returned to UCL in 2019 as Professor in Sport and Exercise Medicine.

He is a member of the ESRC Grant Assessment Panel. He has been recognised as a Highly Cited Researcher in 2018 and 2019, demonstrated by the production of multiple highly-cited papers that rank in the top 1% by citations for field and year (Cross-Field) in Web of Science.

Sir Andy Haines is Professor of Environmental Change and Public Health with a joint appointment in the Dept of Social and Environmental Health Research and in the Dept of Population Health.

He was previously Director (originally Dean) of LSHTM for nearly 10 years up to October 2010, having previously been Professor of Primary Health Care at UCL between 1987-2000. 

Between 1993-6 Professor Haines was on secondment as Director of Research & Development at the NHS Executive, North Thames and he was consultant epidemiologist at the MRC Epidemiology and Medical Care Unit between 1980-7. He has also worked internationally in Nepal, Jamaica, Canada and the USA.

Sir Andy has been a member of a number of major international and national committees, including the MRC Global Health Group ( chair) and the MRC Strategy Group. He was formerly chair of the Universities UK Health and Social Care Policy Committee and a member of the WHO Advisory Committee on Health Research. He was a member of Working Group 2 of the UN Intergovernmental Panel on Climate Change for the second and third assessment reports. He chaired the Scientific Advisory Panel for the 2013 WHO World Health Report on Research for Universal Health Coverage and in 2014/2015 he chaired the Rockefeller Foundation/Lancet Commission on Planetary Health and co-chaired the development group for the Health Knowledge Action Network of Future Earth. He was co-chair of the European Academies Science Advisory Committee working group on climate change and health in Europe, which published its report in June 2019.

Sir Andy currently co-chairs the InterAcademy Partnership (~140 science academies worldwide) working group on climate change and health and the Royal Society/ Academy of Medical Sciences group on health and climate change mitigation. He also co-chairs the Lancet Pathfinder Commission on health in the zero-carbon economy and participates in the Lancet Commissionon Pollution and the Lancet Commission on the COVID-19 response.

Professor Alice Smith leads the Leicester Kidney Lifestyle Team, a large multidisciplinary research group which aims to help kidney patients achieve the best possible health and wellbeing through appropriate lifestyle management. The team strive to produce high quality research and to involve patients, carers, healthcare professionals and stakeholders as partners to ensure delivery of research that meets the needs and expectations of our ultimate user-groups. Professor Smith’s research portfolio includes ~20 single- and multi-centre clinical trials, many of which are adopted on the NIHR portfolio, and have recruited some 6,000 participants since 2010.

Professor Smith’s primary research interest is the role of physical activity, exercise and lifestyle management in kidney disease. Her specific background is in inflammation and immune function but her translational research programme encompasses lab-based exploratory and mechanistic work, outcome measure evaluation, observational and epidemiological studies, clinical efficacy trials, lifestyle intervention development and effectiveness testing, implementation and service evaluation. A strong track record of patient involvement and engagement, and qualitative exploration of patient perspectives and experience underpins all the work.

Emeritus Professor Bauman AO is Sesquicentenary Professor of Public Health and Director of the Prevention Research Collaboration at the University of Sydney. He has academic expertise in many aspects of the primary prevention of chronic disease, with an emphasis on physical activity and obesity prevention epidemiology, population-level interventions and policy research. He has a strong interest in research translation and in the evaluation of complex preventive health programs.

Professor Bauman co-directs the WHO Collaborating Centre on Physical Activity, Nutrition and Obesity, and has assisted in the development of national physical activity and NCD prevention policy, plans and surveillance systems in many countries.

He is a world-leading public health researcher who has for over 30 years, studied chronic disease prevention and the development and assessment of prevention research methods.

Professor Bauman has worked extensively in the fields of physical activity, obesity, smoking and cardiovascular disease prevention as well as other areas relating to health promotion and prevention science. He is a leading authority on research relating to the health consequences of physical activity, and an expert in the consequences of prolonged sitting, including as a risk factor for CV disease and diabetes.

He is a committed advocate for physical activity and health and for research translation into practice to achieve population-wide impact and health equity. Professor Bauman has made many major contributions to prevention science. He was instrumental in identifying the health benefits of moderate physical activity and reduced sitting time. His research also has demonstrated the need for cross-sectoral involvement from areas outside of health in physical activity promotion programs, including diverse sectors such as sports, transport and urban planning to achieve better outcomes. He has developed research methods for evaluating large community-wide public health campaigns, and has contributed to evaluating many public health social marketing and mass media campaigns.

Professor Bauman also builds innovative research-policy linkages and conducts policy-relevant research. His international physical activity surveillance work is being used globally as part of WHO non-communicable disease surveillance.

Professor Bauman holds numerous honorary appointments and visiting Professorships (in four countries). He was listed on the Thompson_Reuter (Clarivate) list of the 1% most cited researchers in any discipline in 2015, 2016 ,2017 and 2018. He is Foundation Fellow of the Australiasian Faculty of Public Health Medicine and an elected Fellow of the Academy of Health and Medical Sciences.